CryoPort (CYRX) Stock Price, News & Analysis

Company Overview

Cryoport, Inc. (NASDAQ: CYRX) provides temperature-controlled logistics and supply-chain solutions for the life sciences industry. The company supports the transportation, storage and management of sensitive biological materials, including cell and gene therapies, biologics, vaccines, clinical-trial materials and reproductive tissues.

Its offerings include specialized cryogenic and refrigerated shipping systems, monitoring and tracking technologies, logistics coordination, packaging and storage services, and related bioservices. Cryoport’s solutions are designed to help maintain required temperature conditions and chain of custody throughout the movement of biological materials from manufacturers and research organizations to clinical sites and other destinations.

Founded in 1999, Cryoport serves pharmaceutical, biotechnology, healthcare and research customers internationally. The company operates through a global network of logistics, storage and support facilities and has expanded its capabilities through businesses such as MVE Biological Solutions, which provides cryogenic equipment and systems, and CRYOPDP, a provider of specialty logistics services for the life sciences sector.

Key Stats

• Today's Range: $16.51 to $17.05
• 50-Day Range: $14.71 to $17.13
• 52-Week Range: $7.61 to $17.20
• Volume: 856,796 shs
• Average Volume: 484,260 shs
• Market Capitalization: $862.05 million
• P/E Ratio: N/A
• Dividend Yield: N/A
• Price Target: $18.00
• Consensus Rating: Moderate Buy

CryoPort Stock Analysis - MarketRank™

CryoPort scored higher than 38% of companies evaluated by MarketBeat, and ranked 655th out of 897 stocks in the healthcare sector. Scores are calculated by averaging available category scores, with extra weight given to analysis and valuation.

Analyst's Opinion

• Score: 2.8 / 5
• Analyst Rating: Moderate Buy

Consensus Rating

CryoPort has received a consensus rating of Moderate Buy. The company's average rating score is 2.67, and is based on no strong buy ratings, 7 buy ratings, 1 hold rating, and 1 sell rating.

Upside/Downside

The consensus price target for CryoPort is close to its current price, suggesting limited near-term upside or downside.

Amount of Analyst Coverage

CryoPort has been the subject of 5 research reports in the past 90 days, demonstrating strong analyst interest in this stock.

Earnings and Valuation

• Score: 0.6 / 5
• Proj. Earnings Growth: Growing

Earnings Growth

Earnings for CryoPort are expected to grow in the coming year, from ($0.83) to ($0.78) per share.

Price to Earnings Ratio vs. the Market

The P/E ratio of CryoPort is -18.91, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.

Price to Earnings Ratio vs. Sector

The P/E ratio of CryoPort is -18.91, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.

Price to Book Value per Share Ratio

CryoPort has a P/B Ratio of 1.85. P/B Ratios below 3 indicates that a company is reasonably valued with respect to its assets and liabilities.

Short Interest

• Score: 1.0 / 5
• Short Interest Level: Bearish

Percentage of Shares Shorted

5.92% of the float of CryoPort has been sold short.

Short Interest Ratio / Days to Cover

CryoPort has a short interest ratio ("days to cover") of 4.85.

Change versus previous month

Short interest in CryoPort has recently increased by 7.88%, indicating that investor sentiment is decreasing significantly.

Dividend

• Score: 0.0 / 5
• Dividend Strength: N/A

Dividend Yield

CryoPort does not currently pay a dividend.

Dividend Growth

CryoPort does not have a long track record of dividend growth.

News and Social Media

• Score: 3.1 / 5
• News Sentiment: 0.95

News Sentiment

CryoPort has a news sentiment score of 0.95. This score is calculated as an average of sentiment of articles about the company over the last seven days and ranges from 2 (good news) to -2 (bad news). This is a higher news sentiment than the 0.56 average news sentiment score of Healthcare companies.

News Coverage This Week

MarketBeat has tracked 6 news articles for CryoPort this week, compared to 3 articles on an average week.

Company Ownership

• Score: 1.8 / 5
• Insider Trading: Selling Shares

Insider Buying vs. Insider Selling

In the past three months, CryoPort insiders have sold more of their company's stock than they have bought. Specifically, they have bought $0.00 in company stock and sold $429,408.00 in company stock.

Percentage Held by Insiders

9.50% of the stock of CryoPort is held by insiders.

Percentage Held by Institutions

92.90% of the stock of CryoPort is held by institutions. High institutional ownership can be a signal of strong market trust in this company.

Company Calendar

• Last Earnings: 8/06/2026
• Today: 9/20/2026
• Next Earnings (Estimated): 11/03/2026
• Fiscal Year End: 12/31/2026

Industry, Sector and Symbol

• Stock Exchange: NASDAQ
• Sector: Healthcare
• Industry: Life Sciences Tools & Services
• Sub-Industry: Life Sciences Tools & Services
• Current Symbol: NASDAQ:CYRX
• CIK: 1124524
• Web: www.cryoportinc.com
• Phone: (949) 470-2300
• Fax: 949-470-2306
• Employees: 738
• Year Founded: 1999

Price Target and Rating

• Average Price Target for CryoPort: $18.00
• High Price Target: $25.00
• Low Price Target: $12.50
• Potential Upside/Downside: +5.8%
• Consensus Rating: Moderate Buy
• Rating Score (0-4): 2.67
• Research Coverage: 9 Analysts

Profitability

• EPS (Trailing Twelve Months): ($0.90)
• Trailing P/E Ratio: N/A
• Forward P/E Ratio: N/A
• P/E Growth: N/A
• Net Income: $78.30 million
• Net Margins: -20.05%
• Pretax Margin: -16.63%
• Return on Equity: -7.20%
• Return on Assets: -4.30%

Debt

• Debt-to-Equity Ratio: N/A
• Current Ratio: 2.08
• Quick Ratio: 1.98

Sales & Book Value

• Annual Sales: $186.45 million
• Price / Sales: 4.62
• Cash Flow: N/A
• Price / Cash Flow: N/A
• Book Value: $9.19 per share
• Price / Book: 1.85

Miscellaneous

• Outstanding Shares: 50,649,000
• Free Float: 45,837,000
• Market Cap: $862.05 million
• Optionable: Optionable
• Beta: 1.89